Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Apraclonidine and clonidine: a comparison of efficacy and side effects in normal and ocular hypertensive volunteers.
Yüksel N, Güler C, Caglar Y, Elibol O. Yüksel N, et al. Among authors: guler c. Int Ophthalmol. 1992 Sep;16(4-5):337-42. doi: 10.1007/BF00917987. Int Ophthalmol. 1992. PMID: 1358852 Clinical Trial.
Electrocardiographic changes during subconjunctival injections.
Kayikçioglu O, Kayikçioglu M, Erakgün T, Güler C. Kayikçioglu O, et al. Among authors: guler c. Int Ophthalmol. 1999;23(1):37-41. doi: 10.1023/a:1006486207583. Int Ophthalmol. 1999. PMID: 11008897
Fluorescein dye disappearance test in patients with different degrees of epiphora.
Toprak AB, Erkin EF, Kayikçioğlu O, Seymenoğlu G, Güler C, Unlu HH. Toprak AB, et al. Among authors: guler c. Eur J Ophthalmol. 2002 Sep-Oct;12(5):359-65. doi: 10.1177/112067210201200503. Eur J Ophthalmol. 2002. PMID: 12474916 Clinical Trial.
Effects of betaxolol and latanoprost on ocular blood flow and visual fields in patients with primary open-angle glaucoma.
Erkin EF, Tarhan S, Kayikçioğlu OR, Deveci H, Güler C, Göktan C. Erkin EF, et al. Among authors: guler c. Eur J Ophthalmol. 2004 May-Jun;14(3):211-9. doi: 10.1177/112067210401400305. Eur J Ophthalmol. 2004. PMID: 15206646 Clinical Trial.
Adverse effects of topical antiglaucoma drugs on the ocular surface.
Arici MK, Arici DS, Topalkara A, Güler C. Arici MK, et al. Among authors: guler c. Clin Exp Ophthalmol. 2000 Apr;28(2):113-7. doi: 10.1046/j.1442-9071.2000.00237.x. Clin Exp Ophthalmol. 2000. PMID: 10933774
Extracapsular cataract extraction with posterior chamber lens implantation in capsular glaucoma.
Arici MK, Topalkara A, Demircan S, Erdoğan H, Güler C. Arici MK, et al. Among authors: guler c. Ophthalmologica. 2000;214(4):260-3. doi: 10.1159/000027501. Ophthalmologica. 2000. PMID: 10859508
In vitro potency and stability of fortified ophthalmic antibiotics.
Arici MK, Sümer Z, Güler C, Elibol O, Saygi G, Cetinkaya S. Arici MK, et al. Among authors: guler c. Aust N Z J Ophthalmol. 1999 Dec;27(6):426-30. doi: 10.1046/j.1440-1606.1999.00239.x. Aust N Z J Ophthalmol. 1999. PMID: 10641902
In all of the antibiotics, pH changed at 24 degrees C after 7-10 days; however, at 4 degrees C, only the pH of tobramycin exhibited changes after 14 days (P<0.05). ...CONCLUSION: Topical fortified antibiotic solutions used for longer than 7 days should be stored …
In all of the antibiotics, pH changed at 24 degrees C after 7-10 days; however, at 4 degrees C, only the pH of tobramycin exhi …
Effect of conjunctival structure and inflammatory cell counts on intraocular pressure after trabeculectomy.
Arici MK, Demircan S, Topalkara A, Güler C, Aker H, Arici DS. Arici MK, et al. Among authors: guler c. Ophthalmologica. 1999;213(6):371-5. doi: 10.1159/000027457. Ophthalmologica. 1999. PMID: 10567869
Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.
Kimal Arici M, Topalkara A, Güler C. Kimal Arici M, et al. Among authors: guler c. Int Ophthalmol. 1998;22(1):37-42. doi: 10.1023/a:1006176713983. Int Ophthalmol. 1998. PMID: 10090447 Clinical Trial.
The determination of additive effect and intraocular pressure lowering effects of 0.05% bromocriptine and 0.25% timolol.
Elibol O, Güler C, Arici K, Topalkara A, Demircan S. Elibol O, et al. Among authors: guler c. Int Ophthalmol. 1996-1997;20(1-3):53-5. doi: 10.1007/BF00212946. Int Ophthalmol. 1996. PMID: 9112164 Clinical Trial.
85 results
Jump to page
Feedback